Transgenic animals and method for bioproduction
AssigneesApplied Stemcell, Inc., The Regents of the University of Michigan
InventorsRuby Yanru TSAI, Jie XU, Yuqing CHEN, Jifeng ZHANG, Ling-jie KONG
Life of this patent
Estimating the term…
Loading patent…
AssigneesApplied Stemcell, Inc., The Regents of the University of Michigan
InventorsRuby Yanru TSAI, Jie XU, Yuqing CHEN, Jifeng ZHANG, Ling-jie KONG
Estimating the term…
Provided is a genetically modified non-human mammal that comprises an anchor DNA sequence inserted at an endogenous locus of a secretory milk protein gene, wherein the anchor DNA sequence comprises a site-specific recombinase recognition site. Also provided is a genetically modified non-human mammal that comprises a transgene inserted at an endogenous locus of a secretory milk protein gene, wherein the transgene encodes a secretory protein and is operably linked to the endogenous promoter of said secretory milk protein gene, and wherein the transgene is flanked by a pair of site-specific recombinase resulting sites. The genetically modified non-human mammals provided can be used for producing the secreted recombinant protein encoded by the transgene from the milk produced by the genetically modified non-human mammals.
A genetically modified non-human mammal comprising an anchor DNA sequence inserted at an endogenous locus of a secretory milk protein gene, wherein said anchor sequence comprises a first site-specific recombinase recognition site.
A genetically modified non-human mammal comprising a transgene inserted at an endogenous locus of a secretory milk protein gene, wherein said transgene encodes a secretory protein and is operably linked to the endogenous promoter of said secretory milk protein gene, and wherein said transgene is flanked by a first site-specific recombinase resulting site and a second site-specific recombinase resulting site.
The non-human mammal of claim of 11, wherein the transgene comprises a polyA sequence at its 3′ end.
The non-human mammal of claim of 11, wherein the transgene encodes a therapeutic protein selected from the group consisting of antigen binding proteins, antibodies, vaccines, fusion proteins, enzymes, co-enzymes, and lysosomal proteins.
A method for making a genetically modified non-human mammal, comprising
A method for making a genetically modified non-human mammal, comprising
Dependencies are inferred from the claim text.